Safety of Oral Vancomycin in Functionally Anephric Patients
- 1 October 1978
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 14 (4), 634-635
- https://doi.org/10.1128/aac.14.4.634
Abstract
Administration of a vancomycin oral solution, 2 g daily for 16 days, to functionally anephric patients without inflammatory bowel disease resulted in assayable but low (≤0.66 μg/ml) serum levels in two of the five volunteers.This publication has 7 references indexed in Scilit:
- Infection in Acute Leukemia Patients Receiving Oral Nonabsorbable AntibioticsAntimicrobial Agents and Chemotherapy, 1978
- Vancomycin RevisitedAnnals of Internal Medicine, 1978
- Sensitive Bioassay for VancomycinAntimicrobial Agents and Chemotherapy, 1978
- Clindamycin-Associated Colitis in Hamsters: Protection with VancomycinGastroenterology, 1977
- PROTECTIVE EFFECT OF VANCOMYCIN ON CLINDAMYCIN-INDUCED COLITIS IN HAMSTERS1977
- Some laboratory and clinical experiences with a new antibiotic, vancomycin.1956